Release Date: 12/12/11 13:54 Summary: Initial Director's Interest Notice - R Gordon Price Sensitive: No Download Document 274.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%